Related Experiment Videos
[Gradually diminishing tumor protection caused by reimplants]
Revista Espanola De Oncologia
|January 1, 1984
Summary
Repeated tumor cell transplants in mice diminish immune protection, leading to increased mortality and a graft-versus-host-like reaction. This phenomenon, termed "bradyphylaxis," highlights complex immune responses to cancer progression.
Area of Science:
- Immunology
- Oncology
- Pathology
Context:
- Studies investigate the long-term immune response following surgical removal of primary tumors.
- Mice with previously resected MCA-induced sarcomas were subjected to repeated tumor cell challenges.
- The study observed changes in protective immunity and survival rates after serial tumor inoculations.
Purpose:
- To elucidate the mechanisms underlying the loss of tumor-specific immunity after repeated antigen exposure.
- To characterize the pathological outcomes and mortality patterns in mice undergoing serial tumor cell transplants.
- To investigate the potential role of graft-versus-host (GVH) reactions in tumor-bearing hosts.
Summary:
- Mice with resected sarcomas showed diminishing protection against subsequent tumor cell transplants over time.
- Increased mortality was observed with repeated inoculations, with a higher proportion of deaths occurring without detectable tumors or dissemination.
- Histopathological findings included significant congestion and hemorrhages in multiple organs, suggesting systemic inflammatory responses.
Impact:
- Identifies 'bradyphylaxis' as a state of progressively diminishing protection induced by repeated tumor challenge.
- Suggests that tumor recurrence or mortality can occur through mechanisms beyond localized tumor growth, potentially involving immune dysregulation.
- Provides insights into the complex interplay between the host immune system, tumor cells, and long-term cancer management strategies.